ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1844

Risk Factors for Complicated Pneumonia in Systemic Lupus Erythematosus (SLE)

Gabriela García-Guevara1, Ricardo Ríos-Corzo2, Juan Ávila-Vázquez3, John Hernández-Flores4, Eduardo Carrillo-Maravilla5, Juan Jakez-Ocampo6, Hilda Fragoso-Loyo7, Luis Llorente8 and Yemil Atisha-Fregoso9, 1Vasco de Quiroga #15, Tlalpan, Belisario Domínguez Sección XVI, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Mexico, 2Escuela de Medicina, Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, Mexico, 3Escuela Nacional de Medicina, Instituto Tecnológico y de Estudios Superiores de Monterrey, Mexico, Mexico, 4Escuela de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico, 5Medicina Interna, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Mexico, 6Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, Mexico, 7Vasco de Quiroga 15 Col Seccio, INNCMSZ-Departamento de Inmunología y Reumato, Mexico, Mexico, 8Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 9Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: infection and risk assessment, Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Pneumonia, remains as a main cause of mortality in patients with SLE. In patients without autoimmune disease, scores as Pneumonia Severity Index (PSI) and CURB-65 can identify patients at low risk of complications. These indexes has not been validated in patients with SLE. 

The aim of this study was to stablish the rate of complications of patients with SLE and pneumonia, identify specific risk factors associated with bad prognosis in these patients and describe the clinical behavior of PSI and CURB-65 to identify patients at low risk of complications.

Methods:

We retrospectively reviewed medical records of patients with SLE (ACR criteria) and pneumonia who attended the emergency room in a single tertiary care center, (January 2010 – March 2015). We collected laboratory and clinical data: demographics, treatment, risk factors commonly associated with poor outcome in pneumonia, and disease activity (SLEDAI-2K). Patients were followed for 30 days after discharge. A composite negative outcome were defined as need of mechanical ventilation (MV), septic shock or death during follow up.

Statistics. Initially we conducted a univariate analysis, using Student T, Mann-Whitney U, Chi squared or Fisher’s exact test as appropriate. Thereafter we conducted a multivariate analysis (logistic regression) with all variables with a p value ≤ 0.10.

Results:

We included 163 patients (121 women, 74%), who presented 194 episodes of pneumonia. At evaluation the mean ± SD age was 34.6 ± 12.4 years. Time since diagnosis of SLE 7.1 ± 8.2 years. SLEDAI 2K was 8 ± 5.6.

Duration of hospitalization was 10.7 ± 7.2 days. Fifty seven (29%) patients had the composite outcome: 13 (7%) septic shock, 50 (26%) needed MV and 12 (6%) patients died.

Variables who reach clinical significance in the univariate analysis were: body mass index (BMI) (higher risk for patients with BMI lower than 19), chronic kidney disease, congestive heart failure, use of methotrexate and use of tacrolimus. Clinical variables with significant association were respiratory rate (RR), heart rate (HR), body temperature, oxygen saturation (detected by pulse oximetry), leukopenia, confusion, changes in pH and procalcitonin levels.

In the multivariate analysis remain significant: low BMI (beta exponential 4.02, 95% CI 1.4 – 11.6, p=0.010), RR (beta exp 1.08, 95% CI 1.02 – 1.15, p=0.006), HR (beta exp 1.04, 95% CI 1.02 – 1.06, p=0.001), body temperature (beta exp 0.46, 95% CI 0.28 – 0.75, p=0.002) and arterial pH (beta exp 0.001, 95% CI 0.00001 – 0.079, p=0.002).

Twenty nine patients (14.9%) had zero points in CURB65 (low risk), 4 of them (13.8%) had an adverse outcome. A score of zero in CURB65 had a sensitivity of 93% and specificity of 18% for identifying patients without complications. Sixty patients were classified as Class I in PSI, 7 of them had a negative outcome. Class I in PSI had a sensitivity of 88% and specificity of 39% for identifying patients without complications.

Conclusion:

In this study none SLE associated variable was significant associated with bad prognosis in patients with SLE and pneumonia. PSI and CURB65 are in general accurate but misclassified about 10% of patients as low risk, so clinical judgement must complement these tools.


Disclosure: G. García-Guevara, None; R. Ríos-Corzo, None; J. Ávila-Vázquez, None; J. Hernández-Flores, None; E. Carrillo-Maravilla, None; J. Jakez-Ocampo, None; H. Fragoso-Loyo, None; L. Llorente, None; Y. Atisha-Fregoso, None.

To cite this abstract in AMA style:

García-Guevara G, Ríos-Corzo R, Ávila-Vázquez J, Hernández-Flores J, Carrillo-Maravilla E, Jakez-Ocampo J, Fragoso-Loyo H, Llorente L, Atisha-Fregoso Y. Risk Factors for Complicated Pneumonia in Systemic Lupus Erythematosus (SLE) [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/risk-factors-for-complicated-pneumonia-in-systemic-lupus-erythematosus-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-factors-for-complicated-pneumonia-in-systemic-lupus-erythematosus-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology